Mark H. Norman

Chapter 13:The Discovery of TRPV1 Antagonists: Turning up the Heat

Mark H. Norman, 2010 .

Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans

Mark J. Rose, Andrej A. Romanovsky, A. A. Romanovsky, 2008, PAIN.

AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties

Mark H. Norman, J. Treanor, T. Vanderah, 2005, Journal of Pharmacology and Experimental Therapeutics.